13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)

Page 2 of 11

Page 2 of 11 – SEC Filing

CUSIP No.   37244C101   Page   2   of   11   Pages
1

NAMES OF REPORTING PERSONS

Baker Bros. Advisors LP

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ¨

(b) ¨

3

SEC USE ONLY

4

SOURCE OF FUNDS (See Instructions)

OO

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7

SOLE VOTING POWER

13,917,146 (1)

8

SHARED VOTING POWER

0

9

SOLE DISPOSITIVE POWER

13,917,146 (1)

10

SHARED DISPOSITIVE POWER

0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

13,917,146 (1)

12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

40.4% (1)(2)

14

TYPE OF REPORTING PERSON (See Instructions)

IA, PN

(1) Includes 81,015 shares of the common stock of Genomic Health, Inc. (the “Issuer”) underlying options directly held
by Julian C. Baker, 56,265 shares of the Issuer’s common stock underlying options directly held by Felix J. Baker, 22,438
shares of the Issuer’s common stock directly held by Julian C. Baker and 6,593 shares of the Issuer’s common stock
directly held by Felix J. Baker.
(2) Based on 34,342,231 shares of the Issuer’s common stock outstanding as of April 30, 2017, as reported in the Issuer’s
Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on May 10, 2017.

Follow Genomic Health Inc (NASDAQ:GHDX)

Page 2 of 11